Related Experiment Video

Updated: Jul 3, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

Enhanced fluid management with continuous venovenous hemofiltration in pediatric respiratory failure patients

Nancy G Hoover1, Michael Heard, Christopher Reid

  • 1Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC, USA.

Intensive Care Medicine
|July 17, 2008
PubMed

Insights

Continuous venovenous hemofiltration (CVVH) alongside extracorporeal membrane oxygenation (ECMO) improved fluid balance and caloric intake in pediatric respiratory failure patients. CVVH also reduced diuretic use compared to standard ECMO therapy.

Area of Science:

  • Pediatric critical care medicine
  • Renal replacement therapy
  • Cardiopulmonary support

Background:

  • Children on extracorporeal membrane oxygenation (ECMO) for respiratory failure often experience fluid overload and renal issues.
  • Standard medical therapies during ECMO may not adequately address fluid balance challenges.

Purpose of the Study:

  • To evaluate the impact of adding continuous venovenous hemofiltration (CVVH) to ECMO in pediatric patients with respiratory failure.
  • To compare fluid balance, medication use, and clinical outcomes between ECMO patients with and without CVVH.

Main Methods:

  • Case-matched study comparing pediatric patients receiving ECMO with CVVH to those receiving ECMO alone.
  • Analysis of fluid balance, medication administration (furosemide), time to caloric intake, and survival rates.

Main Results:

  • Survival rates were similar between the CVVH and non-CVVH groups (P = 0.51).
  • ECMO survivors treated with CVVH demonstrated improved fluid balance (median 25.1 ml kg(-1) day(-1) vs. 40.2 ml kg(-1) day(-1); P = 0.028).
  • Patients receiving CVVH achieved desired caloric intake faster (1 day vs. 5 days; P < 0.001) and required less furosemide (0.67 mg kg(-1) day(-1) vs. 2.11 mg kg(-1) day(-1); P = 0.009).

Conclusions:

  • The integration of CVVH with ECMO in pediatric respiratory failure is associated with enhanced fluid management.
  • CVVH facilitates quicker nutritional support and reduces the need for diuretic medications.
  • CVVH offers a potential benefit in managing fluid overload in critically ill children on ECMO.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...